O TYM PODKAŚCIE 🔗
The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland and covers a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world.
The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends. If you like to join us as a sponsor or advertisers, download our media kit (https://adc.expert/oncozine_media_kit).
If you are living in the US, sign up for our newsletter by texting the words CANCER to 66866.
Become a supporter of this podcast: https://www.spreaker.com/podcast/the-onco-zine-brief--2786156/support.
The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends. If you like to join us as a sponsor or advertisers, download our media kit (https://adc.expert/oncozine_media_kit).
If you are living in the US, sign up for our newsletter by texting the words CANCER to 66866.
Become a supporter of this podcast: https://www.spreaker.com/podcast/the-onco-zine-brief--2786156/support.
Prowadzący:
Częstotliwość aktualizacji:
every 40 days
Średnia długość dźwięku:
43 minutes
Wywiady gościnne
Ma sponsorów
Podcast wideo
Język angielski
Stany Zjednoczone
107 odcinków
od 16 grudnia 2017
episodic
W TYM PODKAŚCIE 🔗
NAJNOWSZY ODCINEK 🔗
In this episode of The Onco’Zine Brief Peter Hofland talks with Stephen Spellman. Stephen Spellman is Vice President and Senior Scientific Director at Be The Match and the Center for International Blood & Marrow Transplant Research (CIBMTR). Hofland and Spellman talk about the outcomes of a stu…
WYSZUKAJ MINIONE ODCINKI
Wyszukaj minione odcinki The Onco'Zine Brief.
POPRZEDNIE ODCINKI 🔗
In a new episode of The Onco’Zine Brief, Peter Hofland talks with Ely Benaim, MD, the Chief Medical Officer and Executive Vice President Development at SonALAsense and Mark De Souza, Ph.D, President and Chief Executive Officer of SonALAsense.SonALAsense was founded to create hope in the face of des…
In a new episode of The Onco’Zine Brief, Peter Hofland talks with Jeffery Auletta, MD is Senior Vice President, Patient Outcomes and Experience, National Marrow Donor Program® (NMDP)/Be The Match®.Be The Match® is a global leader in bone marrow transplantation. The organization conducts research to…
In a new episode of The Onco'Zine Brief, Peter Hofland talks with David M. Cognetti, MD, a Professor and Chair in the Department Head and Neck Surgery at Thomas Jefferson University Hospital in Philadelphia.Hofland and Cognetti talk about head and neck cancer and a novel treatment approach called P…
In this episode of The Onco'Zine Brief, Peter Hofland talks with two experts about their research and the impact the outcomes from these studies may have on the treatment of patients diagnosed with cancer.First, Hofland talks with Christopher Heery, MD.Dr Heery is a board-certified medical oncologi…
Antibody-drug conjugates or ADCs are a class of biopharmaceutical drugs designed as a targeted therapy for treating cancer. However, unlike chemotherapy, ADCs are intended to directly target and kill tumor cells while, at the same time sparing normal, healthy cells. Antibody-drug conjugates consist…
In December 2022 the annual meeting of the American Society of Hematology took place in the vibrant city of New Orleans and brought together tens of thousands of participants from across the world to present and discuss the results of studies that ranged from initial hypothesis to practice-changing…
In the 100th episode of the Onco’Zine Brief, Peter Hofland, Ph.D. talks with Stephen Spellman, Vice President of Research and Senior Scientific Director of the Center for International Blood and Marrow Transplant Research at the National Marrow Donor Program/Be the Match. In the program today Hofla…
In this edition of The Onco'Zine Brief, Peter Hofland, Ph.D, talks with Susanna F. Greer, Ph.D. the Chief Scientific Officer of the V Foundation. In her role, Dr. Greer is a visionary ambassador of the V Foundation, who works with the foundation’s Scientific Advisory Committee to steer funding to t…
Despite availability of endocrine therapies for advanced or metastatic breast cancer, there remains a critical unmet need for more effective and convenient treatment options that improve both the patient experience and health outcomes.In today’s episode of The Onco’Zine Brief, Peter Hofland, Ph.D. …
Zastrzeżenie: Podcast i grafika osadzone na tej stronie pochodzą z Peter Hofland, który jest własnością jego właściciela i nie jest powiązany ani wspierany przez Listen Notes, Inc.
WYSZUKIWARKA PODCASTÓW
Możesz skorzystać z naszej strony internetowej, aby wyszukiwać podcasty3,820,941i odcinki195,298,021według osób, miejsc lub tematów.
Inwestycja w wiedzę przynosi największe zyski, dlatego słucham podcastów.
‐ Benjamin "Llamacorn" Franklin
WYSZUKAJ MINIONE ODCINKI
Wyszukaj minione odcinki The Onco'Zine Brief.
PODCAST ZOSTAŁ ZGŁOSZONY
This podcast page is claimed and managed by
@hofland
TEN PODCAST JEST WYSZUKIWANY...
Sponsorzy
Goście
Współgospodarze
Wzajemna promocja
Jeśli jesteś zainteresowany(a), skontaktuj się.
twórca tego podcastu
See other ogłoszenia drobne
EDYTUJ
Dziękujemy za pomoc w aktualizowaniu podcastowej bazy danych.
